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Qualitative researchA B S T R A C T
Setting: Namibia faces a high burden of tuberculosis (TB) and HIV-infection. In 2011, 50% of
the TB patients were co-infected with HIV. While all patients co-infected with TB and HIV
are eligible for antiretroviral treatment (ART), only 54% were reported to have received ART
according to national data.
Objective: To explore the perspective of healthcare professionals on barriers to access to
ART for HIV-positive TB patients.
Design: Nine semi-structured qualitative interviews were conducted with healthcare pro-
fessionals from TB and HIV services in Windhoek in 2012 to investigate access barriers
to ART for HIV-positive TB patients in Namibia.
Results: Many barriers known from other African countries were also present in Namibia.
The barriers rated as most important were: staff shortage (health system level); limited
training (healthcare worker level); and fear of stigma and discrimination (patient/commu-
nity level). Direct treatment costs and limited availability of antiretroviral medication were
not observed as barriers. Interference with TB treatment and ART by some Pentecostal
churcheswas revealed as an important barrier that has not yet received sufficient attention.
Conclusion: The study identified access barriers to ART for HIV-positive TB patients and their
relevance in Namibia. The findings provide evidence for tailored interventions to increase
ART-uptake among HIV-positive TB patients.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction
The strongest risk factor for developing active tuberculosis
(TB) is infection with human immunodeficiency virus (HIV).In 2012, an estimated 13% of the 8.6 million new TB patients
worldwide were co-infected with HIV. About three quarters
of them lived in Africa. TB is a leading contributor to mortality
among people living with HIV (PLHIV) [1].as), nina.
Table 1 – Summary of major TB/HIV indicators in Namibia, 2007–2011; adapted from Ref. [6].
Indicator 2007 2008 2009 2010 2011
Number of notified cases of all
forms of TB
15,244 13,737 13,332 12,625 11,937
TB case notification rate for all
forms of TB per 100,000
722 665 634 589 556
TB cases with known HIV status (as
percentage of all notified TB cases)
8,186
(54%)
9,188
(67%)
9,849
(74%)
9,534
(76%)
10,039
(84%)
TB patients with known HIV status
who are HIV-positive (as percentage
of all TB patients with known HIV
status)
4,358
(59%)
5,425
(59%)
5,676
(58%)
5,227
(55%)
4,980
(50%)
HIV-positive TB patients on ART (as
percentage of all TB patients with
known positive HIV status)
749
(17%)
2,019
(37%)
1,995
(35%)
2,294
(43%)
2,700
(54%)
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of antiretroviral therapy (ART) reduces morbidity and mortal-
ity. The 2010 World Health Organization (WHO) guidelines for
antiretroviral therapy recommend ART for co-infected
patients irrespective of CD4 cell count as soon as possible
after starting TB treatment [2]. However, ART uptake is often
poor or treatment is delayed in low-resource settings [1].
Namibia, an upper middle income country [3] in sub-
Saharan Africa, has incorporated early initiation of ART for
TB/HIV patients in the national ART guidelines in 2010 [4]
and in the national TB guidelines in 2012 [5]. TB and HIV pro-
grams in Namibia are set up as independent and vertically
structured programs. With 556 new TB cases per 100,000
persons notified in 2011, Namibia has one of the highest TB
incidence rates in the world [6]. HIV prevalence among adults
aged 15–49 years is also very high estimated to be 13.4% in
2011 [7]. Table 1 gives an overview of major TB/HIV indicators
in Namibia. HIV status was documented for 84% of the TB
cases in 2011; 50% of the TB patients with known HIV status
were HIV-positive and 54% of them were on ART [6]. The
relatively low national figures of co-infected TB/HIV patients
on ART in Namibia may partly be due to underreporting as a
result of incomplete register documentation. Information
regarding ART is routinely entered in the TB registers at the
start of TB treatment. Later ART uptake is not consistently
documented and notified to the authorities [8]. Actual figures
at completion of TB treatment may therefore be higher than
the recorded data suggest, but the scale of the documentation
gap has not been determined.
Research conducted in other African countries revealed
various barriers to accessing ART for TB/HIV co-infected
patients at the health-system, healthcare-worker and
patient/community level [9–19], yet there are no publications
from the Namibian context. This study is the first to research
underlying causes for the low proportion of ART uptake
among HIV-positive TB patients in Namibia.
Methods
Qualitative research following the methodology by Meuser
and Nagel [20] for key informant interviews was conducted
from August to December 2012 with nine healthcareprofessionals from TB and HIV services in the Namibian cap-
ital, Windhoek. A qualitative approach was chosen because
qualitative methods are suitable for exploring problems that
cannot be determined exactly beforehand in contrary to a
quantitative approach that measures previously defined
constructs in a standardized form.
Study design
A semi-structured interview guide was developed based on a
literature review [9–19,21] and pre-tested with Namibian
healthcare professionals. The focus was a discussion of
potential barriers to access to ART for HIV-positive TB
patients in Namibia. Interviewees were also asked to perform
a structured rating of the importance of barriers (categories:
very important, important, not so important, no barrier).
The interviews were conducted in English by the principal
investigator, a physician with a background in public health.
Selection of interview partners
The selection of interview partners was performed in consul-
tation with the National Tuberculosis and Leprosy Programme
(NTLP). Triangulation of perspectives was attained through
the purposive sample of six nurses from TB and HIV
services, one community counselor, one field promoter from
non-governmental community-based TB care and one
District Tuberculosis and Leprosy Coordinator (DTLC). Public
health facilities included large and small units with and
without an HIV clinic.
Data collection
Access to interview partners was facilitated by the DTLC. All
contacted key informants agreed to be interviewed. Informed
consent was explicitly obtained for digital recording and ver-
batim transcription.
Analysis
Data analysis was undertaken following Meuser’s and Nagel’s
method of content analysis for key informant interviews [20].
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paragraphs and revised several times. An inductive process of
coding was used to identify analytical categories as they
emerged from the data.
Limitations
A general weakness of the key informant interview approach
is that the quality of the results depends highly on the inter-
viewee’s willingness to provide truthful information [20]. Care
was therefore taken to reassure the participants that the aim
of the study was to identify the potential for reducing chal-
lenges in service provision and improving patient care and
not to test their knowledge and compliance with guidelines.
Attention was paid to potential researcher bias, particu-
larly in light of the different cultural backgrounds of inter-
viewer and interviewees. Findings were discussed with
further Namibian healthcare professionals prior to analysis
to avoid misinterpretation.
Since barriers are likely to vary substantially between
rural and urban settings, the results cannot be taken as
representative of the national situation in Namibia. Research
regarding the patients’ perspectives would complement the
results.0 1 2
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The study is in line with data privacy regulations and ethics
requirements of Charite´ University Medical Center Berlin.
The research project was registered and granted ethical
approval by the Research Management Committee of the
Ministry of Health and Social Services in Namibia on 7 August
2012.Results
Figs. 1–3 display access barriers to ART for HIV-positive TB
patients according to their ranking and grouped by barriers
at the health system level, at the healthcare worker level
and at the patient/community level. The topics are presented
in this order in the results section, while the discussion of
barriers in the following section is guided by their relevance
and contextual relationship.
Barriers at the health system level
Staff shortage in TB and HIV services is regarded as the most
important barrier by the interviewees. They describe a gen-
eral problem with nurses resigning and difficulties in filling3 4 5 6 7 8 9
Number of ratings by interviewees
t so important no barrier not answered
the health system level.
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Fig. 3 – Rating of barriers at the patient and community level.
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in the TB department due to fear of infection. The intervie-
wees observe that understaffing leads to a lack of time for
individual patients and may compromise motivation and
quality of work. High staff turnover due to rotation or resigna-
tion of staff is also regarded as an important barrier. Even a
short-term absence of the familiar nurse may decrease adher-
ence to TB treatment: ‘‘When I came back from leave, they were
gone, all [the patients] were gone. I ended up calling ‘Where are
you?’ [The patients asked] ‘Are you back?’, so they just came back’’
(TB nurse).
Lack of adequate counseling space is also perceived as a
major barrier. Patients are often counseled in rooms where
nurses and even other patients go in and out: ‘‘They [the coun-
seling colleagues] use the conference room, but there is no privacy’’
(HIV nurse).
Many interviewees see a barrier in physical accessibility of
HIV services and list difficulties like distance from place of
residence, limited opening hours and long waiting times.
Four interviewees regard limitations in the referral system
between TB and HIV services as a barrier. Referrals are made
without standardized referral forms, and there are no referral
registers for documentation. Interviewees have developed dif-
ferent strategies to keep track of referrals, but they are not
systematically applied.
The majority of interviewees did not regard limitations in
recording and reporting of TB/HIV data as a barrier. However,
neither counseling for and referral to HIV testing or counsel-
ing for ART and referral to HIV care are systematically
documented.
Most of the interviewees did not see a barrier in limited
coordination of TB and HIV services. Yet, there are no joint
training workshops or supervisory meetings and no mutual
staff meetings of nurses from TB and HIV services. Further-
more, reconciliation of TB and HIV data is not performed.
The interviewees report no out-of-stock situations of
antiretrovirals (ARVs) in their facilities.Barriers at the healthcare worker level
Inadequate training of healthcare workers is regarded as an
important or very important barrier by all the interviewees:
‘‘. . .not all our nurses who work in TB are trained in HIV. They are
just using their own common sense’’ (DTLC). New TB nurses are
invited to attend a workshop on TB management, including
a module on TB/HIV co-infection, but not always in a timely
manner. Some interviewees also perceive supervision as
insufficient. In addition, all the interviewees rate inadequate
knowledge on the part of the healthcare workers as an impor-
tant barrier. Delayed training, missing refresher training and
lack of time for training and supervision are reported as the
main causes.
Several interviewees felt the need for training in commu-
nication skills: ‘‘Because if you scare the patient, forget that
the patient will open up. It doesn’t matter what race or what tribe
the patient is, you can overcome this with communication’’ (HIV
nurse).
Some interviewees have observed stigmatizing and dis-
criminating behavior of other healthcare workers against TB
patients: ‘‘Sometimes the TB nurse did not go for training and when
the patient comes, she don’t want even to touch the patient’’ (field
promoter). Stigma and discrimination of healthcare workers
against HIV-positive patients was not reported.
Barriers at the patient/community level
Interviewees rate fear of stigma and discrimination as the
main barrier to HIV treatment on the part of the patients, stat-
ing thatmany patients prefer not to be seen at the HIV clinic or
taking the antiretroviral medication. ‘‘You know, no one wants to
be seen walking around with a big container. Because people out
there know big white containers they are ARVs’’ (HIV nurse).
Four interviewees regard language issues as a very impor-
tant barrier. Translations to local languages are mostly deliv-
ered by other healthcare workers and relatives, but
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concerns about privacy and quality of translations.
Six interviewees regard religious issues as a barrier. They
report an increasing number of patients who have been
encouraged by Pentecostal churches to stop taking their
ARTor other drug treatment and rely on healing through faith
and prayer instead. ‘‘If the church finds out that they are on ARV,
the church will say ‘Bring your medication to church and we will
throw them away and we will start praying for you’. And then they
stop their treatment’’ (TB nurse).
Interference by traditional healers is, in contrast, not
regarded as a major barrier.
All the interviewees agree that lack of knowledge on the
part of the patients is an access barrier because understand-
ing of the benefits of ART supports the decision to get an HIV
test and to start ART.
Fear of indirect treatment costs (loss of income, expenses
for transport or extra food) are perceived as a barrier by most
of the interviewees: ‘‘They cannot take the medication on their
empty tummies’’ (TB nurse). On the other hand, fear of direct
treatment costs is not regarded as a barrier since HIV services
including ART are offered at no cost.
The interviewees report that most TB patients get tested
for HIV without hesitation. The remaining patients agree after
repeated counseling, but some keep declining. Interviewees
assume fear of stigma and discrimination, ignorance and
denial as main causes behind a decline or delay of HIV testing.
Some interviewees see a link between culture and access
to ART, and name traditions, beliefs and social norms of dif-
ferent ethnic groups as barriers. ‘‘Some races feel like that, this
is not a disease for them, it’s a disease for other people. And even
if they are sick, dying sick, they won’t be tested’’ (HIV nurse).
Most of the interviewees have experienced that patients
have reservations regarding the medication burden of ARVs
on top of the TB treatment, especially with respect to poten-
tial side effects and toxicities.
Four interviewees classify gender issues as a barrier
with challenges for both male and female patients. While
male patients seem to struggle with their pride, female
patients appear to be more concerned about disclosure:
‘‘The females, they are still afraid: ‘What will my husband
say?’’’ (HIV nurse).Discussion
According to the interviewees, Provider Initiated HIV Counsel-
ing and Testing (PICT) is routinely offered to TB patients and
HIV-positive patients are routinely offered ART, in keeping
with national and international guidelines [5,22]. Training of
TB nurses is ongoing and access to ART is improving for
TB/HIV patients in Namibia. However, a number of barriers
on different levels were identified in this study.
Barriers at the health system level
Interviewees perceived staff shortage as a major challenge in
service provision and as the most important access barrier
to ART for TB/HIV patients at the health system level. High
staff turnover due to attrition or rotation was also rated asan important barrier that brings about loss of experienced per-
sonnel and disrupts the close relationship between TB
patients and their nurses. High workload due to inadequate
human resources capacity may compromise the quality of
patient care and administrative processes (e.g., recording
and reporting), may decrease the time for training and super-
vision andmay reduce productivity andmotivation [23]. Given
the severe shortage of healthcare workers in Namibia [24], the
reluctance of nurses towork in TB services due to fear of infec-
tion is of particular concern. This obstacle to adequate staffing
in TB units should be actively addressed by imparting knowl-
edge on the actual risk of TB infection to all clinical staff. Also,
national TB infection control guidelines must be updated in
order to reflect the latestWHO policy [25,26], and implementa-
tion of the guidelines must be improved [27].
In line with literature, lack of adequate space for undis-
turbed counseling in privacy was rated as a barrier in this
study [9]. Also, various obstacles to accessibility of HIV care,
like long waiting times or cost of transport that are known
from literature, were also observed in this study [21]. It can
be assumed that transport factors pose a bigger challenge in
rural areas [13]. Accessibility of HIV care could be improved
by scaling up and integrating TB and HIV services. One-stop-
services for co-infected patients, e.g., rapid HIV testing by TB
nurses, should be offered as recommended by WHO [28].
Referrals between TB and HIV services are performed
without standardized referral tools and procedures. Given
the absence of feedback loops, like referral forms with back-
ward slip and referral registers, failed referrals may go unno-
ticed [9]. WHO acknowledges a well-functioning referral
system as a precondition for the effective delivery of HIV care
to TB patients when TB and HIV services are not fully inte-
grated [28]. The introduction of standard referral processes
with closed loops would contribute to the success of referrals.
Important collaborative activities, like joint training and
supervision or regular meetings of TB and HIV staff, are not
performed at the facility level implying deficits in service
coordination [9]. WHO regards these activities as success fac-
tors for the strengthening of referral linkages between verti-
cally organized TB and HIV programs [28].
The study revealed substantial deficiencies in immediate
and systematic documentation of HIV-related patient infor-
mation. Inconsistent recordkeeping was already observed in
Namibian TB services [27]. It is acknowledged as a barrier to
ART [9] and implies underreporting of national data. This
may partly account for the considerable discrepancy between
the nurses’ impression that most of the TB patients are tested
for HIV and started on ART if the test comes out positive,
while the figures in the TB registers are much lower [6]. In
contrast to literature from other countries [9,14], ARV avail-
ability was not a barrier in the facilities that participated in
the study. Indeed, ARV availability in Namibia was reported
as almost 100% in public facilities during the time period
2007–2010 [29].
Barriers at the healthcare worker level
Inadequate communication skills, training, supervision and
knowledge of healthcare workers were all regarded as barriers
of high relevance by the interviewees, in line with literature
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nurses in TB services, timely training on the national TBman-
agement guidelines should be ensured before the assignment.
The introduction of regular refresher training, a need
expressed by several nurses, could contribute to the renewal
and consolidation of knowledge over the course of the
placement. Supportive supervision should be an integral part
of the routine training package and include detailed
guidance on referrals and their documentation. In addition,
special training on counseling and communication skills
would be beneficial tomeet the particular needs of co-infected
patients [10]. At this, the reduction of staff shortages plays an
important role in ensuring sufficient time for training and
supervision.
Stigma and discrimination at health facilities was deter-
mined as an impediment to ART initiation [21]. In this study,
interviewees mainly described discriminating behavior of
healthcare workers against co-infected patients being a result
of fear of TB infection due to the airborne mode of transmis-
sion. Therefore, all staff in health facilities should be edu-
cated regarding the risk of an infection with TB, trained in
TB infection control and made aware of stigmatizing and
discriminating behavior.
Barriers at the patient/community level
The fear of stigma and discrimination was rated as the most
important barrier on the part of the patients. It puts patients
under psychosocial distress and may lead to a delay or
rejection of HIV testing [15] and ART commencement [16].
Knowledge about the linkage of TB and HIV and about the
benefits of ART is regarded as crucial for accepting the offer
to get tested [11]. Efforts should therefore be made to
intensify the dissemination of TB/HIV information and to
fight stigma and discrimination in society. Since cultural
background plays an important role in the individual
response to HIV-related stigma [15,17], counseling and health
education of patients should be adapted to cultural
characteristics.
Speaking the same language as clinical staff is an important
factor for the success of counseling [18]. In this study, commu-
nication problems due to the multiplicity of languages in
Namibia turned out to be an important barrier. Since transla-
tions are not performed by professional interpreters, care must
be taken to ensure that the patient feels comfortable with
respect to privacy and that the information is well understood.
Interference by traditional healers was regarded as a
minor barrier. By contrast religious interferencewith TB treat-
ment, and especially ART, by Pentecostal churches turned out
to be a serious problem in this study. Faith healing is part of
the Pentecostal belief system, including healing of diseases
that are classified as incurable in scientific medicine like
HIV infection [30]. Interviewees report an increasing number
of patients defaulting treatment because some Pentecostal
churches in Namibia encourage their congregations to stop
taking medication against HIV and other diseases. ‘Born
again’ religion was recently described as a barrier to adher-
ence to ART in other African countries [19,31], but has not
yet been the subject of medical research in Namibia. It is a
significant finding of this study that the practices of Pentecos-tal churches may compromise TB therapy and ART in
Namibia. This development is not yet addressed in the
national response to TB and HIV.
Fear of direct treatment costs for ART seems not to be a
barrier. In contrast, indirect costs are perceived as a challenge
for many patients. The literature shows that concerns
regarding ART are often related to poverty, either with respect
to loss of income [32] or to expenditures, e.g., for transport
[12]. The expected medication burden also causes concerns,
mainly due to possible toxicities and interactions [14] but also
regarding the amount and quality of food needed while on
treatment [12]. Patients should therefore receive thorough
information up–front to clarify possible misconceptions
[12,16].
The identification of gender-specific challenges for women
and for men is in line with research from other countries
[33,34]. Healthcare workers should be trained to carefully take
gender-related aspects into account in counseling and clinical
care of TB/HIV patients.Conclusions
This study identified access barriers to ART for TB/HIV
patients and their relevance in Namibia. The most important
barriers are related to general shortages of staff and limita-
tions in their training. Fear of stigma and discrimination
remains a major barrier on the part of the patients. A surpris-
ing finding is the interference with TB and HIV treatment by
Pentecostal churches.
The study results highlight the importance of addressing
the challenges in the areas of staffing and training. The train-
ing package should include communication skills that
address the particular needs of dually infected patients and
promote gender-sensitive and culturally adapted counseling
approaches. TB/HIV collaborative activities must be strength-
ened. Referral loops should be introduced, and the documen-
tation of HIV-related patient information in TB services needs
to be improved. The TB and HIV services should be integrated
as much as possible, especially at the service provision level,
to ensure comprehensive care for co-infected patients. Fur-
thermore, the practices of Pentecostal churches interfering
with drug therapy need to be researched and addressed.
The study provides evidence for targeted interventions to
increase uptake of antiretroviral therapy for HIV-positive TB
patients in Namibia. The findings have been disseminated
to the Namibian Ministry of Health and Social Services.Conflict of interest
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